Cargando…
Characterization of CYPs and UGTs Involved in Human Liver Microsomal Metabolism of Osthenol
Osthenol is a prenylated coumarin isolated from the root of Angelica koreana and Angelica dahurica, and is an O-demethylated metabolite of osthole in vivo. Its various pharmacological effects have been reported previously. The metabolic pathway of osthenol was partially confirmed in rat osthole stud...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161247/ https://www.ncbi.nlm.nih.gov/pubmed/30200214 http://dx.doi.org/10.3390/pharmaceutics10030141 |
_version_ | 1783358945863139328 |
---|---|
author | Cho, Pil Joung Paudel, Sanjita Lee, Doohyun Jin, Yun Ji Jo, GeunHyung Jeong, Tae Cheon Lee, Sangkyu Lee, Taeho |
author_facet | Cho, Pil Joung Paudel, Sanjita Lee, Doohyun Jin, Yun Ji Jo, GeunHyung Jeong, Tae Cheon Lee, Sangkyu Lee, Taeho |
author_sort | Cho, Pil Joung |
collection | PubMed |
description | Osthenol is a prenylated coumarin isolated from the root of Angelica koreana and Angelica dahurica, and is an O-demethylated metabolite of osthole in vivo. Its various pharmacological effects have been reported previously. The metabolic pathway of osthenol was partially confirmed in rat osthole studies, and 11 metabolic products were identified in rat urine. However, the metabolic pathway of osthenol in human liver microsomes (HLM) has not been reported. In this study, we elucidated the structure of generated metabolites using a high-resolution quadrupole-orbitrap mass spectrometer (HR-MS/MS) and characterized the major human cytochrome P450 (CYP) and uridine 5′-diphospho-glucuronosyltransferase (UGT) isozymes involved in osthenol metabolism in human liver microsomes (HLMs). We identified seven metabolites (M1-M7) in HLMs after incubation in the presence of nicotinamide adenine dinucleotide phosphate (NADPH) and uridine 5′-diphosphoglucuronic acid (UDPGA). As a result, we demonstrated that osthenol is metabolized to five mono-hydroxyl metabolites (M1-M5) by CYP2D6, 1A2, and 3A4, respectively, a 7-O-glucuronide conjugate (M6) by UGT1A9, and a hydroxyl-glucuronide (M7) from M5 by UGT1A3 in HLMs. We also found that glucuronidation is the dominant metabolic pathway of osthenol in HLMs. |
format | Online Article Text |
id | pubmed-6161247 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61612472018-10-01 Characterization of CYPs and UGTs Involved in Human Liver Microsomal Metabolism of Osthenol Cho, Pil Joung Paudel, Sanjita Lee, Doohyun Jin, Yun Ji Jo, GeunHyung Jeong, Tae Cheon Lee, Sangkyu Lee, Taeho Pharmaceutics Article Osthenol is a prenylated coumarin isolated from the root of Angelica koreana and Angelica dahurica, and is an O-demethylated metabolite of osthole in vivo. Its various pharmacological effects have been reported previously. The metabolic pathway of osthenol was partially confirmed in rat osthole studies, and 11 metabolic products were identified in rat urine. However, the metabolic pathway of osthenol in human liver microsomes (HLM) has not been reported. In this study, we elucidated the structure of generated metabolites using a high-resolution quadrupole-orbitrap mass spectrometer (HR-MS/MS) and characterized the major human cytochrome P450 (CYP) and uridine 5′-diphospho-glucuronosyltransferase (UGT) isozymes involved in osthenol metabolism in human liver microsomes (HLMs). We identified seven metabolites (M1-M7) in HLMs after incubation in the presence of nicotinamide adenine dinucleotide phosphate (NADPH) and uridine 5′-diphosphoglucuronic acid (UDPGA). As a result, we demonstrated that osthenol is metabolized to five mono-hydroxyl metabolites (M1-M5) by CYP2D6, 1A2, and 3A4, respectively, a 7-O-glucuronide conjugate (M6) by UGT1A9, and a hydroxyl-glucuronide (M7) from M5 by UGT1A3 in HLMs. We also found that glucuronidation is the dominant metabolic pathway of osthenol in HLMs. MDPI 2018-08-30 /pmc/articles/PMC6161247/ /pubmed/30200214 http://dx.doi.org/10.3390/pharmaceutics10030141 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Cho, Pil Joung Paudel, Sanjita Lee, Doohyun Jin, Yun Ji Jo, GeunHyung Jeong, Tae Cheon Lee, Sangkyu Lee, Taeho Characterization of CYPs and UGTs Involved in Human Liver Microsomal Metabolism of Osthenol |
title | Characterization of CYPs and UGTs Involved in Human Liver Microsomal Metabolism of Osthenol |
title_full | Characterization of CYPs and UGTs Involved in Human Liver Microsomal Metabolism of Osthenol |
title_fullStr | Characterization of CYPs and UGTs Involved in Human Liver Microsomal Metabolism of Osthenol |
title_full_unstemmed | Characterization of CYPs and UGTs Involved in Human Liver Microsomal Metabolism of Osthenol |
title_short | Characterization of CYPs and UGTs Involved in Human Liver Microsomal Metabolism of Osthenol |
title_sort | characterization of cyps and ugts involved in human liver microsomal metabolism of osthenol |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161247/ https://www.ncbi.nlm.nih.gov/pubmed/30200214 http://dx.doi.org/10.3390/pharmaceutics10030141 |
work_keys_str_mv | AT chopiljoung characterizationofcypsandugtsinvolvedinhumanlivermicrosomalmetabolismofosthenol AT paudelsanjita characterizationofcypsandugtsinvolvedinhumanlivermicrosomalmetabolismofosthenol AT leedoohyun characterizationofcypsandugtsinvolvedinhumanlivermicrosomalmetabolismofosthenol AT jinyunji characterizationofcypsandugtsinvolvedinhumanlivermicrosomalmetabolismofosthenol AT jogeunhyung characterizationofcypsandugtsinvolvedinhumanlivermicrosomalmetabolismofosthenol AT jeongtaecheon characterizationofcypsandugtsinvolvedinhumanlivermicrosomalmetabolismofosthenol AT leesangkyu characterizationofcypsandugtsinvolvedinhumanlivermicrosomalmetabolismofosthenol AT leetaeho characterizationofcypsandugtsinvolvedinhumanlivermicrosomalmetabolismofosthenol |